Elekta Nomination Committee's proposed Board of Directors for the 2019 Annual General Meeting
The Nomination Committee's complete proposal will be published in the notice of Elekta's Annual General Meeting 2019, to be held on August 22, 2019 at 2:00 pm at Moderna Museet in Stockholm.
The Nomination Committee, prior to the 2019 Annual General Meeting, comprises the following members: Laurent Leksell (Chairman), with direct and indirect holdings; Per Colleen, appointed by Fjärde AP-Fonden; Filippa Gerstädt, appointed by Nordea Fonder; Thomas Flodén, appointed by AMF and AMF Fonder; and Caroline Sjösten, appointed by Swedbank Robur Funds. The chairman of the Nomination Committee is Laurent Leksell.
# # #
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: Cecilia.Ketels@elekta.com
Time zone: CET: Central European Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com (http://www.elekta.com) or follow @Elekta (https://twitter.com/Elekta)on Twitter.